Clinical OncologyHereditary Breast & Ovarian CancerEarly Risk StratificationGenetic Counselling Support
Genetic Screening Research Group
Investigating complex disease genetics and providing precision molecular screening services.
Evidence led
Validated methodology
CEMB quality
Research you can trust
Practical impact
From lab to real life
Trusted CEMB research & services
Why it matters
Scientific Significance & Real-World Value
CEMB's genetic screening service helps assess inherited risk for breast and ovarian cancer, using DNA analysis to identify pathogenic variants associated with hereditary cancer syndromes.
Results are intended to support informed clinical decision-making alongside genetic counselling, not to replace a full clinical evaluation.
Evidence-led outcome
Genetic testing to help assess inherited breast and ovarian cancer risk, supporting early detection and informed care.
Core Benefits at a Glance
DNA-based hereditary risk assessment
Supports early detection and preventive care planning
Findings should be interpreted with genetic counselling